An evaluation of inflammatory gene polymorphisms in sibships discordant for premature coronary artery disease: The GRACE-IMMUNE study

BMC Medicine

Volumn 8, Issue , 2010, Pages

  Brown, Benjamin D ^a   Nsengimana, Jérémie ^b   Barrett, Jennifer H ^b   Lawrence, Richard A ^a   Steiner, Lori ^c   Cheng, Suzanne ^c   Bishop, D Timothy ^b   Samani, Nilesh J ^d   Ball, Stephen G ^a   Balmforth, Anthony J ^a   Hall, Alistair S ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL RECEPTOR; CD14 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EOTAXIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 9; LEUKOTRIENE C4 SYNTHASE; LYMPHOTOXIN; PADGEM PROTEIN; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR 7; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; CYTOKINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GENDER; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; HAPLOTYPE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; AGE; COHORT ANALYSIS; FAMILY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; CORONARY ARTERY DISEASE; CYTOKINES; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-1; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 76949100016     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-5     Document Type: Article

References (34)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-125. 10.1056/NEJM199901143400207, 9887164.
2. Lusis JA, Mar R, Pajukanta P. Genetics of atherosclerosis. Annu Rev Genomics Hum Genet 2004, 5:189-218. 10.1146/annurev.genom.5.061903.175930, 15485348.
3. Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S, Grams SE, Walker K, Steiner LL, Cree BAC, Stillman A, Lincoln RR, Pericak-Vance MA, Haines JL, Erlich HA, Hauser SL, Oksenberg JR. Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann Neurol 2004, 55:793-800. 10.1002/ana.20092, 15174013.
4. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. GRR: graphical representation of relationship errors. Bioinformatics 2001, 17:742-743. 10.1093/bioinformatics/17.8.742, 11524377.
5. Goring HH, Ott J. Relationship estimation in affected sib pair analysis of late-onset diseases. Eur J Hum Genet 1997, 5:69-77.
6. Boehnke M. Allele frequency estimation from data on relatives. Am J Hum Genet 1991, 48:22-25. 1682747, 1985459.
7. Rabinowitz D, Laird NM. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered 2000, 50:211-223. 10.1159/000022918, 10782012.
8. Lake SL, Blacker D, Laird NM. Family-based tests of association in presence of linkage. Am J Hum Genet 2000, 67:1515-1525. 10.1086/316895, 1287928, 11058432.
9. STATA Corp Stata Statistical Software: Release 9. TX: StataCorp LP. 2005, STATA Corp.
10. Siegmund KD, Langholz B, Kraft P, Thomas DC. Testing linkage disequilibrium in sibships. Am J Hum Genet 2000, 67:244-248. 10.1086/302973, 1287084, 10831398.
11. Nsengimana J, Barrett JH. Power, validity, bias and robustness of family-based association analysis methods in the presence of linkage for late onset diseases. Ann Hum Genet 2008, 72:793-800. 10.1111/j.1469-1809.2008.00475.x, 2659381, 18782299.
12. Zhang K, Sun F, Zhao H. HAPLORE: a program for haplotype reconstruction in general pedigrees without recombination. Bioinformatics 2005, 21:90-103. 10.1093/bioinformatics/bth388, 15231536.
13. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002, 53:79-91. 10.1159/000057986, 12037407.
14. Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, Pato MT, Petryshen TL, Kolonel LN, Lander ES, Sklar P, Henderson B, Hirschhorn JN, Altshuler D. Assessing the impact of population stratification on genetic association studies. Nat Genet 2004, 36:388-393. 10.1038/ng1333, 15052270.
15. Isoda K, Sawada S, Ayaori M, Matsuki T, Horai R, Kagata Y, Miyazaki K, Kusuhara M, Okazaki M, Matsubara O, Iwakura Y, Ohsuzu F. Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice. J Biol Chem 2005, 280:7002-7009. 10.1074/jbc.M412220200, 15574426.
16. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M. Lack of interleukin-1 beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23:656-660. 10.1161/01.ATV.0000064374.15232.C3, 12615675.
17. Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, Froland SS, Semb AG, Aukrust P, Damas JK. Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of hmg-coa reductase inhibitors. Circulation 2004, 109:1966-1972. 10.1161/01.CIR.0000125700.33637.B1, 15051633.
18. Ikonomidis I, Lekakis JP, Nikolaou M, Paraskevaidis I, Andreadou I, Kaplanoglou T, Katsimbri P, Skarantavos G, Soucacos PN, Kremastinos DT. Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation 2008, 117:2662-2669. 10.1161/CIRCULATIONAHA.107.731877, 18474811.
19. Abbate A, Salloum FN, Vecile E, Das A, Hoke NN, Straino S, Biondi-Zoccai GG, Houser JE, Qureshi IZ, Ownby ED, Gustini E, Biasucci LM, Severino A, Capogrossi MC, Vetrovec GW, Crea F, Baldi A, Kukreja RC, Dobrina A. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation 2008, 117:2670-83. 10.1161/CIRCULATIONAHA.107.740233, 18474815.
20. Crossman DC, Morton AC, Gunn JP, Greenwood JP, Hall AS, Fox KA, Lucking AJ, Flather MD, Lees B, Foley CE. Investigation of the effect of interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (the MRC-ILA-HEART Study). Trials 2008, 9:8. 10.1186/1745-6215-9-8, 2289802, 18298837.
21. Momiyama Y, Hirano R, Taniguchi H, Nakamura H, Ohsuzu F. Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J Am Coll Cardiol 2001, 38:712-717. 10.1016/S0735-1097(01)01438-3, 11527622.
22. Vohnout B, Di Castelnuovo CA, Trotta R, D'Orazi A, Panniteri G, Montali A, Donati MB, Arca M, Iacoviello L. Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease. Haematologica 2003, 88:54-60.
23. Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R, Del Zotto E, Colombo M, Napoleone E, Amore C, D'Orazio A, Padovani A, de Gaetano G, Giannuzzi P, Donati MB, . IGIGI Investigators Polymorphisms of the interleukin-1 beta gene affect the risk of myocardial infarction and ischaemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 2005, 25:222-227. IGIGI Investigators.
24. Oda K, Tanaka N, Arai T, Araki J, Song Y, Zhang L, Kuchiba A, Hosoi T, Shirasawa T, Muramatsu M, Sawabe M. Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Hum Mol Genet 2007, 16:92-599.
25. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, Kornman KS, Duff GW. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006, 15:519-529. 10.1093/hmg/ddi469, 16399797.
26. Papiol S, Rosa A, Gutiérrez B, Martin B, Salgado P, Catalán R, Arias B, Fañanás L. Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder. J Med Genet 2004, 41:219-223. 10.1136/jmg.2003.012914, 1735684, 14985387.
27. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402. 10.1038/35006081, 10746728.
28. Rahman P, Sun S, Peddle L, Snelgrove T, Melay W, Greenwood C, Gladman D. Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis Rheum 2006, 54:2321-2325. 10.1002/art.21928, 16918024.
29. The BHF Family Heart Study Research Group A genomewide linkage study of 1,933 families affected by premature coronary artery disease: the British Heart Foundation (BHF) family heart study. Am J Hum Genet 2005, 77:1011-1020. 10.1086/498653, 1285159, 16380912, The BHF Family Heart Study Research Group.
30. Nsengimana J, Samani NJ, Hall AS, Balmforth AJ, Mangino M, Yuldasheva N, Maqbool A, Braund P, Burton P, Bishop DT, Ball SG, Barrett JH, . British Heart Foundation Family Heart Study Research Group Enhanced linkage of a locus on chromosome 2 to premature coronary artery disease in the absence of hypercholesterolaemia. Eur J Hum Genet 2006, 15:313-319. 10.1038/sj.ejhg.5201752, 17149386, British Heart Foundation Family Heart Study Research Group.
31. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, Harada E, Masuda T, Koyama W, Saito Y, Miyamoto Y, Ogawa Y, Nakao K. Association of the missense glu298asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998, 31:1506-1510. 10.1016/S0735-1097(98)00167-3, 9626827.
32. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ. A common variant of the endothelial nitric oxide synthase (glu298->asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999, 100:1515-1520.
33. Jachymova M, Horky K, Bultas J, Kozich V, Jindra A, Peleska J, Martasek P. Association of the glu298asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun 2001, 284:426-430. 10.1006/bbrc.2001.5007, 11394896.
34. Shoji M, Tsutaya S, Saito R, Takamatu H, Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in Northern Japan. Life Sciences 2000, 66:2557-2662. 10.1016/S0024-3205(00)00589-0, 10883733.